Nice 40% Return by End of Q1 2022I have loaded up on KNR (once again) and looking forward to a nice 40% return by the end of Q1 next year. This forecast is based in the primary business line for KNR and not BioCloud. Biocloud has not materialized to anything material and unless KNR can cut the cost in half, I don't see a future for it. I think the market has been clear on that for some time now. The 40% return noted above assumes almost no BioCloud sales so if there are some that materialize we could see even nicer returns by the end of March. I will gladly except a 40% return 3 months from now. The upcoming earnings report should be the catalyst to push our stock price to those levels. LTD1